Message from the C-Suite | Future Frontiers in Biomedical Innovation for Healthy Aging
Geneva
|
November 9, 2022
|
Deloitte Consulting
13:20 GMT | 14:20 CET | 8:20am EST
Healthy aging will be spurred by future innovation tackling chronic disease and managing multiple co-morbidities that rise in prevalence with age. Bayer’s Head of Pharmaceuticals will describe some of the most exciting biomedical advancements on the horizon.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.